Cite
Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
MLA
Beck-Schimmer, Beatrice, et al. “Early Sevoflurane Sedation in Severe COVID-19-Related Lung Injury Patients. A Pilot Randomized Controlled Trial.” Annals of Intensive Care, vol. 14, no. 1, Mar. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13613-024-01276-4.
APA
Beck-Schimmer, B., Schadde, E., Pietsch, U., Filipovic, M., Dübendorfer-Dalbert, S., Fodor, P., Hübner, T., Schuepbach, R., Steiger, P., David, S., Krüger, B. D., Neff, T. A., & Schläpfer, M. (2024). Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Annals of Intensive Care, 14(1), 1–11. https://doi.org/10.1186/s13613-024-01276-4
Chicago
Beck-Schimmer, Beatrice, Erik Schadde, Urs Pietsch, Miodrag Filipovic, Seraina Dübendorfer-Dalbert, Patricia Fodor, Tobias Hübner, et al. 2024. “Early Sevoflurane Sedation in Severe COVID-19-Related Lung Injury Patients. A Pilot Randomized Controlled Trial.” Annals of Intensive Care 14 (1): 1–11. doi:10.1186/s13613-024-01276-4.